RMD:ASX
Resmed CDI
A$31.87
arrow_downward
-0.53%(-0.17) 1D
Sep 18, 4:10:25 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RMD...
Open
A$31.91
High
A$32.11
Low
A$31.71
Mkt. cap
32.46B
Avg. vol.
1.66M
Volume
1.36M
52-wk high
A$43.29
52-wk low
A$25.50
Shares outstanding
144.25M
No. of employees
11K
Open
A$31.91
High
A$32.11
Low
A$31.71
Mkt. cap
32.46B
Avg. vol.
1.66M
Volume
1.36M
52-wk high
A$43.29
52-wk low
A$25.50
Shares outstanding
144.25M
No. of employees
11K
News stories
From web sources and news partners
Yahoo Finance
·
3 hours ago
ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures
MarketBeat
·
3 hours ago
Nykredit A S Makes New Investment in ResMed Inc. $RMD
MarketWatch
·
14 hours ago
ResMed Inc. stock falls Friday, underperforms market
AD HOC NEWS
·
20 hours ago
ResMed Inc. stock gains on RBC upgrade and analyst interest
Profile
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed CDI
CEOMichael J. Farrell
Employees11.4K
FoundedJun 1989
HeadquartersSan Diego, California, United States
SectorMedical device
Websiteresmed.com